Zevra Therapeutics is trading at $10.53, up 5.41%, alongside a stronger market; no definitive cause has been established. - The S&P 500 was up 0.70%, and the Nasdaq Composite was up 1.06%. - No fresh company-specific catalyst was identified. Zevra’s investor-relations news page lists its latest release as August 5, 2026, before October 5.